(HealthDay)—Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years and older, the U.S. Food and Drug Administration announced Friday. The agency noted that pediatric patients with GPA, previously known as Wegener’s granulomatosis, and MPA have
Complete Reading

Lauren Tilmont didn’t believe it when her doctor told her a few years ago that he had a treatment that might allow her to eat peanuts, despite a lifelong allergy to them. “The first thing I told him was, “You’re crazy. That doesn’t happen,” ” said Tilmont, 25, of Rogers Park. She had been told
Complete Reading

An immunotherapy and a targeted treatment have been recommended for use on the NHS in Scotland, but a third treatment was rejected. The Scottish Medical Consortium (SMC) approved the use of two new treatment options—dacomitinib (Vizimpro) and pembrolizumab (Keytruda) – for some patients with non small cell lung cancer. But a third lung cancer drug,
Complete Reading

Purdue Pharma has filed for bankruptcy in a settlement agreement that it hopes will provide more than $10 billion to address the opioid crisis, the company said in a statement on Sunday. The pharmaceutical giant whose prescription painkiller OxyContin is blamed for much of the US opioid addiction epidemic, is facing thousands of state and
Complete Reading

It’s only human that decision-making changes when people are rushed. Researchers at the University of Minnesota and Harvard University conducted the first study in the United States to examine this phenomenon—using a national source of electronic health records—in primary care physicians when they decide whether to prescribe opioid painkillers. The findings were recently published in
Complete Reading

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson. One day after the healthcare giant was found guilty of flooding the market with highly addictive painkillers, another top opioid producer, Purdue Pharma,
Complete Reading

Medical researchers often use serum albumin (SA) as a drug carrier to deliver cytotoxic agents to tumors during biomedical drug delivery via passive targeting approaches. To improve the targeting capacity of SA’s a team of scientists recently developed an approach to retain SA-drug conjugates in tumors by combining passive and active targeting mechanisms. In the
Complete Reading

Osteopathic medicine’s emphasis on physician empathy and understanding leads to higher patient satisfaction, a study by researchers at UNTHSC’s Texas College of Osteopathic Medicine indicates. The 2 ½ -year study, conducted by the PRECISION Pain Research Registry and TCOM’s John Licciardone, DO, MS, MBA, reaffirmed the importance of empathy and better interpersonal manner when treating
Complete Reading

Pharmaceutical companies’ payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, and the increasing use of the drug suggests it may be being abused.  “We found that the more physicians receive industry
Complete Reading

Doctors today are reducing their patients’ need for strong opioid medications after surgery by pre-treating patients with other pain relievers before they even enter the operating room. While opioids relieve patients’ pain and suffering, between 8% and 12% of those who take these drugs develop an opioid use disorder. At Keck Medicine of USC, health
Complete Reading

Create Account



Log In Your Account